Kim, Jang-Woon
Kim, Juryun
Lee, Soon Min
Rim, Yeri Alice
Sung, Young Chul
Nam, Yoojun
Kim, Hyo-Jin
Kim, Hyewon
Jung, Se In
Lim, Jooyoung
Ju, Ji Hyeon http://orcid.org/0009-0001-7649-5076
Funding for this research was provided by:
Ministry of Science, ICT and Future Planning (NRF-2019R1A5A2027588, NRF-2021R1C1C2004688)
Catholic Institute of Cell Therapy (CRC in 2024)
College of Medicine, Catholic University of Korea (College of Medicine, Catholic University of Korea)
Article History
Received: 28 November 2023
Accepted: 26 May 2024
First Online: 18 June 2024
Declarations
:
: Title of the approved project; Efficacy evaluation on neuronal protection and regeneration of combined treatment of MNP and BM-102 in contusive spinal cord injury model.Name of the institutional approval committee; The Animal Studies Committee of the School of Medicine, the Catholic University of Korea.Approval Number; IACUC approval Number CUMC-2020-0364-04.Date of approval; 29. December 2021.
: Not application.
: The authors declare that there is no competing interest. Affiliation 4 declares that there is no competing interest. J.K., Y.N., and H.K. are employees at YiPSCELL, Inc., and J.H.J. is the employer. J.H.J. is the founder of YiPSCELL, Inc., and also works at the Seoul St. Mary’s hospital, Catholic University of Korea. The two groups do not have competing interests. Affiliation 5 declares that there is no competing interest. S.M.L., Y.C.S., H.-J. K. are employees at SL BiGen, Inc. The two groups do not have competing interests.